|
SLC25A43 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.881460E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.262200E-02 |
| Normal-vs-Stage2 |
4.553800E-02 |
| Normal-vs-Stage3 |
1.061390E-01 |
| Normal-vs-Stage4 |
8.777000E-01 |
| Stage1-vs-Stage2 |
4.846000E-01 |
| Stage1-vs-Stage3 |
6.053400E-01 |
| Stage1-vs-Stage4 |
5.630200E-01 |
| Stage2-vs-Stage3 |
8.495600E-01 |
| Stage2-vs-Stage4 |
3.410400E-01 |
| Stage3-vs-Stage4 |
4.615800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.742100E-03 |
| Normal-vs-AfricanAmerican |
3.392300E-02 |
| Normal-vs-Asian |
9.833600E-01 |
| Caucasian-vs-AfricanAmerican |
6.901600E-01 |
| Caucasian-vs-Asian |
5.598200E-01 |
| AfricanAmerican-vs-Asian |
5.043000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.224100E-03 |
| Normal-vs-Female |
2.013700E-02 |
| Male-vs-Female |
4.347000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.177600E-01 |
| Normal-vs-Extreme_Weight |
9.828200E-02 |
| Normal-vs-Obese |
4.692100E-02 |
| Normal-vs-Extreme_Obese |
3.367800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.048600E-01 |
| Normal_Weight-vs-Obese |
3.359400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.633200E-01 |
| Extreme_Weight-vs-Obese |
5.606200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.101600E-01 |
| Obese-vs-Extreme_Obese |
8.531600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.918800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.010700E-04 |
| Normal-vs-Age(61-80Yrs) |
1.162970E-01 |
| Normal-vs-Age(81-100Yrs) |
5.419600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.283600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.632800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.617160E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.705800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.245400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.251800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.436360E-02 |
| Normal-VS-Type2 PRCC |
5.806600E-04 |
| Normal-VS-KIRP CIMP |
<1E-12 |
| Normal-VS-Unclassified PRCC |
9.477200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.867800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
<1E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
1.147620E-01 |
| Type2 PRCC-VS-KIRP CIMP |
<1E-12 |
| Type2 PRCC-VS-Unclassified PRCC |
8.841000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.18379775268818E-11 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.249240E-01 |
| Normal-vs-N1 |
5.850000E-01 |
| Normal-vs-N2 |
7.300400E-01 |
| N0-vs-N1 |
6.944400E-01 |
| N0-vs-N2 |
9.553000E-01 |
| N1-vs-N2 |
9.063000E-01 |
|
|
